Clinical trial
Candesartan in the Prevention of Relapsing Atrial Fibrillation
NCT00130975 is registered in ClinicalTrials.gov with Asker & Baerum Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Candesartan in the Prevention of Relapsing Atrial Fibrillation
- Lead sponsor
- Asker & Baerum Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2001
- Completion date
- September 30, 2005
- Enrollment
- 200
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.